Holen Sie sich die Stockscreener-App
1.45
1.05%
0.02
Schlusskurs vom Vortag:
$1.43
Offen:
$1.43
24-Stunden-Volumen:
315.57K
Relative Volume:
0.44
Marktkapitalisierung:
$144.99M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-1.1789
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
-3.02%
1M Leistung:
+0.35%
6M Leistung:
-17.43%
1J Leistung:
-70.57%
1-Tages-Spanne:
$1.42
$1.47
1-Wochen-Bereich:
$1.42
$1.595
52-Wochen-Spanne:
$0.87
$6.37
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.45 | 155.99M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.45 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.38 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.74 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.29 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
294.56 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Should I hold or sell Alector Inc. stock in 2025Invest smarter with daily stock recommendations - Jammu Links News
What makes Alector Inc. stock price move sharplyBoost your wealth with consistent growth stocks - Jammu Links News
How strong is Alector Inc. company’s balance sheetTremendous wealth creation - Jammu Links News
What institutional investors are buying Alector Inc. stockPowerful profit generation - Jammu Links News
Is Alector Inc. a good long term investmentInvest smarter with actionable market insights - Jammu Links News
How does Alector Inc. generate profit in a changing economyAchieve breakthrough financial results today - Jammu Links News
What is the dividend policy of Alector Inc. stockIdentify undervalued stocks ready to soar - Jammu Links News
What is Alector Inc. company’s growth strategyBuild a diversified portfolio for stability - Jammu Links News
Alector Inc. Stock Analysis and ForecastGet exclusive access to professional stock picks - Jammu Links News
How does Alector Inc. compare to its industry peersDiscover high-impact stocks for growth - Jammu Links News
Is it the right time to buy Alector Inc. stockHigh-yield investments - Jammu Links News
Why is Alector Inc. stock attracting strong analyst attentionAchieve rapid financial growth with smart picks - Jammu Links News
What are analysts’ price targets for Alector Inc. in the next 12 monthsBuild a diversified portfolio for steady profits - Jammu Links News
How to build a custom watchlist for Alector Inc.Sector Rotation Strategy for Smart Traders - Newser
Market reaction to Alector Inc.’s recent newsRSI and MACD Signal Summary with Trends - Newser
Identifying reversal signals in Alector Inc.Free AI Powered High Return Stock Calls - Newser
Why Alector Inc. stock attracts strong analyst attentionPortfolio Risk Distribution Analysis Tool - Newser
Alector's Latozinemab Study Advances Neurodegenerative Disease Treatment - AInvest
When is Alector Inc. stock expected to show significant growthExpert Picks Watchlist For Every Investor - Jammu Links News
Alector’s Latozinemab Study: A Promising Step in Neurodegenerative Disease Treatment - TipRanks
What is the risk reward ratio of investing in Alector Inc. stockFinancial News Review For Consistent Profits - Jammu Links News
Risk adjusted return profile for Alector Inc. analyzedReal Chart Based Opportunity Identification - Newser
How to recover losses in Alector Inc. stockShort-Term Stock Trend Forecast Guide - Newser
Is Alector Inc. stock entering bullish territoryRSI and MACD Signal Summary with Trends - Newser
Mizuho Upgrades Alector (ALEC) to Outperform, Raises PT to $3.50 on Q4 2025 Latozinemab Trial Anticipation - Insider Monkey
Alector Inc. Company Revenue and Profit Trends: A Deep DiveHigh Conviction Screener with Trend Matching - Newser
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call - 富途牛牛
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call | ALEC Stock News - GuruFocus
Alector, Inc. to Host Conference Call for Q2 2025 Results and Mid-Year Business Update - Quiver Quantitative
Is Alector Inc. a candidate for recovery playShort-Term Growth Watch with Signal Prediction - Newser
Will Alector Inc. continue its uptrendROI Focused Setup With Drawdown Analysis - Newser
Competitive Positioning of Alector Inc.: Is It Leading or LaggingNews Based Entry Opportunity Alerts Detected - metal.it
How Alector Inc. stock performs during market volatilityMinimal Risk Growth Investment Opportunity Analysis - Newser
Is a relief rally coming for Alector Inc. holdersFree Pattern Detection for Entry Confirmation - Newser
Regression analysis insights on Alector Inc. performancePredictive Screener for Daily Trade Watch - Newser
Is Alector Inc. stock poised for growthIntraday Strategy with Real Time Monitoring - Newser
Can Alector Inc. rally from current levelsOversold Reversal Picks with Buy Zone - Newser
Detecting support and resistance levels for Alector Inc.Day Trading Setup and Momentum Analysis - Newser
Alector, Inc. shares rise 1.86% after-hours following GSK's dementia research progress. - AInvest
Technical Charts Suggest Momentum Shift in Alector Inc.Breakout Momentum Picks With Protection Outlined - metal.it
Top Risks to Consider Before Buying Alector Inc. StockBuy List With Technical Entry Triggers - Newser
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):